Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bio-Path Holdings (BPTH)
NASDAQ:BPTH
Holding BPTH?
Track your performance easily
BPTH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.85 - $14.43
Previous Close$1.08
Volume22.39K
Average Volume (3M)1.42M
Market Cap
$4.16M
Enterprise Value$136.21K
Total Cash (Recent Filing)$4.00M
Total Debt (Recent Filing)$55.00K
Price to Earnings (P/E)―
Beta-0.18
Next Earnings
Nov 15, 2024EPS Estimate
-$1.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-17.86
Shares Outstanding2,552,190
10 Day Avg. Volume155,241
30 Day Avg. Volume1,415,054
Standard Deviation0.23
R-Squared0.00298
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)2.12
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.01
Forecast
1Y Price Target
$20.00Price Target Upside1718.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bio-Path Holdings News
PremiumCompany Announcements
Bio-Path Holdings Raises $4M Through Private Placement
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BPTH FAQ
What was Bio-Path Holdings’s price range in the past 12 months?
Bio-Path Holdings lowest stock price was $0.85 and its highest was $14.43 in the past 12 months.
What is Bio-Path Holdings’s market cap?
Currently, no data Available
When is Bio-Path Holdings’s upcoming earnings report date?
Bio-Path Holdings’s upcoming earnings report date is Nov 15, 2024 which is in 17 days.
How were Bio-Path Holdings’s earnings last quarter?
Bio-Path Holdings released its earnings results on Aug 15, 2024. The company reported -$1.16 earnings per share for the quarter, beating the consensus estimate of -$1.54 by $0.38.
Is Bio-Path Holdings overvalued?
According to Wall Street analysts Bio-Path Holdings’s price is currently Undervalued.
Does Bio-Path Holdings pay dividends?
Bio-Path Holdings does not currently pay dividends.
What is Bio-Path Holdings’s EPS estimate?
Bio-Path Holdings’s EPS estimate is -$1.02.
How many shares outstanding does Bio-Path Holdings have?
Bio-Path Holdings has 3,710,190 shares outstanding.
What happened to Bio-Path Holdings’s price movement after its last earnings report?
Bio-Path Holdings reported an EPS of -$1.16 in its last earnings report, beating expectations of -$1.54. Following the earnings report the stock price went down -1.325%.
Which hedge fund is a major shareholder of Bio-Path Holdings?
Currently, no hedge funds are holding shares in BPTH
---
Bio-Path Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.00 (1718.18% Upside)
$20.00 (1718.18% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 14.7%
Last 30 Days ▲ 14.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.29%
12-Months-Change
Fundamentals
Return on Equity
-366.18%
Trailing 12-Months
Asset Growth
-21.55%
Trailing 12-Months
Company Description
Bio-Path Holdings
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
---
BPTH Earnings Call
Q2 2024
0:00 / 0:00
---
BPTH Stock 12 Month Forecast
Average Price Target
$20.00
▲(1718.18% Upside)
Technical Analysis
Best Analysts Covering BPTH
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-60.97%
reiterated a buy rating 2 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -60.97% per trade.
---